AnaptysBio Execs Show Routine “Sell‑to‑Cover” Moves, Yet CEO, CFO’s Buying Signals Confidence Amid GSK Lawsuit
Explore how AnaptysBio’s top executives’ insider trades reveal confidence—buy‑to‑sell patterns, RSU cover, and leadership stakes—offering insight into the company’s future potential.
4 minutes to read
